| English | Arabic | Home | Login |

SHAKIR ABDULRAHMAN JAMAL Zebari

Area interest

    Laboratory Medicine Hematopathology Transfusion Medicine Haemoglobinopathy Enzymopathy G6PD deficiency premarital screening hepatitis B hepatitis C Blood bank Transfusion medicine benign and malignant hematological disorders

Specialties

    MBCHB D.C. Path FKBMS (Haematopathology)

Language

  • Kurdish (Native language)
  • Arabic (Excellent)
  • English (Very good)

Social Links

Thesis

2025

Frequency and Polymorphism of ABO and Rh (D) Blood Group Antigens among Kurdish Population in Zakho City, Kurdistan Region, Iraq

2025-04-01
Blood group A was found to be most prevalent and detected in 4, 817 (40.4%) of the studied population, followed by group O in 4, 276 (35.9%), then group B in 2, 008 (16.9%), and finally, group AB in 809 (6.8%). Rh (D) positive phenotype was detected in 10, 950 (91.9%), while 980 (8.1%) persons were found to be Rh (D) negative. No significant differences were found between ABO and Rh (D) distribution with either sex or religion.

Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq.

2025-02-11
Zebari S (February 11, 2025) Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq. Cureus 17(2): e78862. doi:10.7759/cureus.78862

A study of relationship between SARS-CoV-2 antibodies levels and host factors among general population in Zakho City, Iraq.

2022
R Hussein, N., A Naqid, I., A Jamal, S. ., Balatay, A. ., Ibrahim, N. ., H Musa, D. ., & S M. Saleem, Z. . (2022). A study of relationship between SARS-CoV-2 antibodies levels and host factors among general population in Zakho City, Iraq. Journal of Contemporary Medical Sciences, 8(4). https://doi.org/10.22317/jcms.v8i4.1256

• COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study.of Northern Iraq. BMC Blood Disorders 2010, 10.6. biomedcentral.com/1471-2326/10/6.

2021
Hussein NR, Balatay AA, Naqid IA, Jamal SA, Rasheed NA, Ahmed AN, Salih RS, Mahdi AS, Mansour SA, Mahdi S, Ibrahim N, Musa DH, Saleem ZS. COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint. medRxiv. 2021; 2021032321254169.

• The Prevalence of Hepatitis B and C Virus Infections in the Couples Attending a Premarital Screening Program in Zakho City, Kurdistan Region of Iraq.

2021
Jamal S A, Naqid I A, Hussein N R, Abdulqader S R, Nimet A A, et al. The Prevalence of Hepatitis B and C Virus Infections in the Couples Attending a Premarital Screening Program in Zakho City, Kurdistan Region of Iraq. Zahedan J Res Med Sci. 2021;23(2):e99405. https://doi.org/10.5812/zjrms.99405.

The Prevalence of Hepatitis B and C Virus in Healthy Women in Zakho City, Kurdistan Region of Iraq

2019
Jamal S A, Naqid I A, Hussein N R, Yousif S H, Yousif S A, et al. The Prevalence of Hepatitis B and C Virus in Healthy Women in Zakho City, Kurdistan Region of Iraq: A Brief Report. J Kermanshah Univ Med Sci. 2019;23(4):e99337. https://doi.org/10.5812/jkums.99337.

The Distributions of HCV Genotypes in Hemodialysis Patients in Iraq

2019
Hussein N, Al-Obeidy E S, Naqid I, Abd K H, Abdulrahman S. The Distributions of HCV Genotypes in Hemodialysis Patients in Iraq. Iran J Med Microbiol. 2019; 13 (4) :279-283

Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.

2016
Al-Allawi N, Mohammad AM, Jamal S. Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq. PLoS One. 2016 Sep 1;11(9):e0162036. doi: 10.1371/journal.pone.0162036. PMID: 27583566; PMCID: PMC5008799.

Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq.

2010
Al-Allawi N, Eissa AA, Jubrael JM, Jamal SA, Hamamy H. Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. BMC Blood Disorder. 2010 Jul 5; 10:6. doi: 10.1186/1471-2326-10-6. PMID: 20602793; PMCID: PMC2913952.
Back